1. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. (25th May 2020) Authors: Krogstad, Paul; Samson, Pearl; Acosta, Edward P; Moye, Jack; Townley, Ellen; Bradford, Sarah; Brown, Emily; Denson, Kayla; Graham, Bobbie; Hovind, Laura; Sise, Thucuma; Teppler, Hedy; Mathiba, Sisinyana Ruth; Fairlie, Lee; Winckler, Jana L; Slade, Gretchen; Meyers, Tammy Journal: Journal of the Pediatric Infectious Diseases Society Issue: Volume 10:Number 2(2021) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV). (22nd July 2020) Authors: Bekker, Adrie; Decloedt, Eric H; Slade, Gretchen; Cotton, Mark F; Rabie, Helena; Cressey, Tim R Journal: Clinical infectious diseases Issue: Volume 72:Number 11(2021) Page Start: 2032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗